NVS ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง7/21/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)1.71
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)14.95B
Novartis AG ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Novartis AG ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Novartis AG ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Novartis AG ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Novartis AG ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
NVS ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง10/27/2026
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)2.31
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)14.47B
NVS FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)7.2121.88%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)56.33B8.91%
Novartis AG(NVS) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 7/21/2026 | 06/2026 | 1.71/2.36 | 14.95B/14.50B | -27.34% | 3.08% |
| 4/28/2026 | 03/2026 | 1.65/2.08 | 13.51B/13.36B | -20.71% | 1.15% |
| 2/4/2026 | 12/2025 | 1.26/1.99 | 13.86B/13.58B | -36.81% | 2.06% |
| 10/28/2025 | 09/2025 | 2.04/2.23 | 14.36B/13.91B | -8.63% | 3.20% |
| 7/17/2025 | 06/2025 | 2.07/2.36 | 14.53B/14.08B | -11.99% | 3.17% |
| 4/29/2025 | 03/2025 | 1.83/2.13 | 13.59B/13.06B | -14.06% | 4.04% |
| 1/31/2025 | 12/2024 | 1.42/1.81 | 13.56B/12.81B | -21.63% | 5.83% |
| 10/29/2024 | 09/2024 | 1.58/1.96 | 13.17B/12.76B | -19.13% | 3.20% |